Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2013
11/21/2013WO2013129935A4 Use of a particulate immunomodulator in cancer therapy
11/21/2013WO2013128419A3 Pharmaceutical compositions comprising boronic acid compounds
11/21/2013WO2013119144A3 Hair growth agent (embodiments) and method for treating hair loss
11/21/2013WO2013112806A3 Transdermal hormone delivery
11/21/2013US20130310930 Ocular implant with double anchor mechanism
11/21/2013US20130310779 Treatment for high pressure bleeding
11/21/2013US20130310740 Long term drug delivery devices with polyurethane based polymers and their manufacture
11/21/2013US20130310665 Method
11/21/2013US20130310460 Modified release formulations of memantine oral dosage forms
11/21/2013US20130310457 Solid-in-oil dispersions
11/21/2013US20130310426 Sustained release aminopyridine composition
11/21/2013US20130310424 Aerosol pirfenidone and pyridone analog compounds and uses thereof
11/21/2013US20130310413 Abuse-deterrent drug formulations
11/21/2013US20130310397 Ternary mixture formulations
11/21/2013US20130310392 Pharmaceutical formulation for topical administration comprising b220
11/21/2013US20130310338 Glucans
11/21/2013US20130310335 Prolonged release bioadhesive therapeutic systems
11/21/2013US20130310319 Fast dissolving pharmaceutical composition
11/21/2013US20130310253 Cholesterol lowering agent, neutral fat lowering agent, blood glucose level lowering agent, cholesterol adsorbent, adsorbent, neutral fat adsorbent, healthy food, health supplement, food with nutrient function claims, food for specified health use, quasi-drug, and pharmaceutical drug
11/21/2013US20130309313 Compositions and Methods for Increasing the Stability of Food Product Additives
11/21/2013US20130309312 Dermal composition comprising polymeric reversed micelle, and method for producing same
11/21/2013US20130309311 Pellet formulation for the treatment of the intestinal tract
11/21/2013US20130309309 Crystalline anti-htnfalpha antibodies
11/21/2013US20130309307 Bilayer Pharmaceutical Tablet Comprising Telmisartan and a Diuretic and Preparation Thereof
11/21/2013US20130309306 Intrapulmonary benzodiazepine for the treatment and prevention of seizures
11/21/2013US20130309304 Compounds and methods
11/21/2013US20130309303 Opiod Agonist Formulations with Releasable And Sequestered Antagonist
11/21/2013US20130309301 Salts of potassium atp channel openers and uses thereof
11/21/2013US20130309299 Therapeutic delivery system
11/21/2013US20130309298 Formulations comprising exine shells
11/21/2013US20130309297 Long-lasting controlled-release liposome composition and method for producing same
11/21/2013US20130309294 New oral dissolving films for insulin administration, for treating diabetes
11/21/2013US20130309292 Tobacco Alkaloid Releasing Chewing Gum
11/21/2013US20130309291 Confection composition
11/21/2013US20130309286 Glucan Compositions
11/21/2013US20130309280 Spinning nanowires and method for inducing cell eradication using same
11/21/2013US20130309279 Solution of carbon monoxide for the treatment of disease, including sickle cell disease
11/21/2013US20130309276 Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same
11/21/2013US20130309274 Wound debridement
11/21/2013US20130309273 Thermostable Vaccine Compositions and Methods of Preparing Same
11/21/2013US20130309227 Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue
11/21/2013US20130309226 High-concentration monoclonal antibody formulations
11/21/2013US20130309219 Treatment and Prevention of Bacterial Vaginosis and Gardnerella Vaginalis Infections
11/21/2013US20130309178 Compositions for aerosolizations of highly conductive solutions
11/21/2013US20130309175 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
11/21/2013US20130309174 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
11/21/2013US20130309173 Methods and compositions for maintenance of a functional wound
11/21/2013US20130309172 Cleavable functionalized nanoparticles
11/21/2013DE102013004199A1 Pharmazeutische Zusammensetzung Pharmaceutical composition
11/21/2013DE102012002372B4 Konzentrat für eine Dialysierflüssigkeit und daraus hergestellte Dialysierflüssigkeit Concentrate for a dialysis fluid and derived dialysis fluid
11/20/2013EP2664625A2 Blood-brain barrier permeable peptide compositions
11/20/2013EP2664330A1 Composition and medication containing Omega 3 fatty acids and a glucosaminoglucan
11/20/2013EP2664329A1 Ophthalmological vehicle system
11/20/2013EP2664328A1 Omega3 fatty acid compound preparation
11/20/2013EP2664324A1 Nanocapsules with a polymer shell
11/20/2013EP2664323A1 Solvent-cast microneedle arrays containing active
11/20/2013EP2664321A2 Medical instrument
11/20/2013EP2663588A1 Functionalised materials, process for the production and uses thereof
11/20/2013EP2663548A1 Pegylated lipids and their use for drug delivery
11/20/2013EP2663337A2 Method for delivering agents into cells using bacterial toxins
11/20/2013EP2663326A1 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
11/20/2013EP2663310A1 Oral dosage forms for modified release comprising tasocitinib
11/20/2013EP2663300A1 Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
11/20/2013EP2663296A1 Donepezil transdermal patch
11/20/2013EP2663295A2 Highly concentrated liquid acetaminophen solutions
11/20/2013EP2663294A2 New hard capsules comprising pullulan
11/20/2013EP2663293A2 Triggered polymer viscous pill and methods of using the same
11/20/2013EP2663292A2 Oral dosage forms of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl]-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amide
11/20/2013EP2663291A1 Compositions comprising crosslinked cation- binding polymers and calcium and/or magnesium cations, and uses thereof
11/20/2013EP2663290A1 Compositions comprising crosslinked cation- binding polymers and a base, uses thereof
11/20/2013EP2663289A2 Cefpodoxime proxetil formulations comprising taste regulating agent
11/20/2013EP2663288A1 Methods for preparing vesicles and formulations produced therefrom
11/20/2013EP2663287A1 Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
11/20/2013EP2663286A1 Preventive effect of citrulline on the spontaneous development of tumors
11/20/2013EP2663285A2 Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
11/20/2013EP2663284A1 Implant comprising a core and a tube encasing the core
11/20/2013EP2663283A1 High drug load tablet formulation of brivanib alaninate
11/20/2013EP2663282A2 Pharmaceutical compositions for the treatment of parasitic diseases, cancer, or skin diseases by topical administration
11/20/2013EP2663281A1 Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
11/20/2013EP2506831B1 Carboxyvinyl polymer-containing nanoparticle suspensions
11/20/2013EP2398512B1 Kit comprising a functionalized adhesive medical gel
11/20/2013EP2344130B9 Pharmaceutical topical compositions
11/20/2013EP2303225B1 Compositions of Carbon Dioxide Adduct of Ertapenem and Polymorphic Forms of Ertapenem Monosodium Salt
11/20/2013EP2233112B1 Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
11/20/2013EP2215047B1 Method of treating vitamin b12 deficiency
11/20/2013EP2120859B1 Sustained-release formulations comprising bmp-7 crystals
11/20/2013EP2085078B1 Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof
11/20/2013EP2074989B1 Abuse resistance opioid transdermal delivery device
11/20/2013EP2004138B1 Gastric raft composition comprising processed starches for inducing satiety
11/20/2013EP1904067B1 Pharmaceutical formulation of carboxamide hiv integrase inhibitors containing a release rate controlling composition
11/20/2013EP1670436B1 Composition comprising ether lipid
11/20/2013CN203291260U Refining liquid mixing system for traditional Chinese medicine pulse-activating injection
11/20/2013CN203291214U Tobacco control active peptide polymerization liquid steam state cigarette
11/20/2013CN103403069A Method for producing powdery coating agents for stable protective coatings for pharmaceutical dosage forms
11/20/2013CN103402543A Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
11/20/2013CN103402532A Enteral nutrient
11/20/2013CN103402527A Compositions and methods for cell transplantation
11/20/2013CN103402512A Colonoscopy - preparation
11/20/2013CN103402504A Sildenafil-free base-containing film preparation and method for producing same
11/20/2013CN103402503A Coated solid pharmaceutical preparation
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 2991